ClinConnect ClinConnect Logo
Search / Trial NCT05231018

A Study on a Digital Platform for COVID19+ Patients, Designed to Facilitate Communication and Mental-health Care During and After Hospitalization.

Launched by FONDAZIONE IRCCS CA' GRANDA, OSPEDALE MAGGIORE POLICLINICO · Feb 8, 2022

Trial Information

Current as of May 11, 2025

Completed

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Age 18-80
  • 2. A positive COVID-19 test at the moment of enrolment for subjects in the 'patients' group
  • 3. Adequate sensory and motor abilities, without impairments in vision, hearing and handling devices
  • 4. Access to Internet wireless technologies.
  • 5. A good level of Italian in terms of speaking, reading and writing.
  • Exclusion Criteria:
  • 1. Present of past medical history of schizophrenia, schizoaffective disorder, delusional disorder, bipolar disorder, current substance abuse, all according to the diagnostic and statistical manual fifth edition (DSM-5) (American Psychiatric Association, 2013).
  • 2. With a diagnosis of cognitive impairment and/or dementia (e.g., mild cognitive impairment, Alzheimer's disease, Parkinson's disease);
  • 3. Intellectual disability defined by a total IQ \< 70 in Test di Intelligenza Breve (TIB) (Sartori et al., 1997) or Standard Progressive Raven Matrices (John \& Raven, 2003)
  • 4. Severe present medical conditions that could interfere with participation.
  • 5. Present or past suicidal ideation or commitment.
  • 6. Significant impairment in the use of digital and technological devices, in questionnaires and test completions, comprehension or with lack of a compliant behavior in the earliest evaluations.
  • 7. Being enrolled in other clinical trials assessing any psychological, or experimental pharmacological treatment.

About Fondazione Irccs Ca' Granda, Ospedale Maggiore Policlinico

Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico is a prestigious research and clinical care institution based in Milan, Italy. Renowned for its commitment to advancing medical knowledge and improving patient outcomes, the foundation integrates cutting-edge research with high-quality healthcare services. It serves as a hub for innovative clinical trials, fostering collaborations among healthcare professionals, researchers, and academic institutions. With a focus on various therapeutic areas, the foundation aims to translate scientific discoveries into effective treatments, ultimately enhancing the quality of life for patients.

Locations

Milano, , Italy

Patients applied

0 patients applied

Trial Officials

Paolo Brambilla

Principal Investigator

Università degli Studi di Milano, Fondazione Policlinico di Milano

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials